BRIEF published on 08/11/2026 at 18:35, 1 month 3 days ago Medincell at Piper Sandler CNS Symposium 2026 Investors Medincell BEPO Technology Piper Sandler CNS Symposium Prolonged Treatments
BRIEF published on 08/11/2026 at 18:35, 1 month 3 days ago Medincell au Piper Sandler CNS Symposium 2026 Investisseurs Medincell Piper Sandler CNS Symposium BEPO Technologie Traitements Prolongés
PRESS RELEASE published on 08/11/2026 at 18:30, 1 month 3 days ago Informations privilégiées / Autres communiqués Medincell participera au Piper Sandler CNS Symposium le 13 août 2026 avec le Dr Grace Kim, CSO, U.S. Finance. L'entreprise développe des traitements injectables à action prolongée pour divers domaines thérapeutiques Medincell Dr Grace Kim Action Prolongée Piper Sandler CNS Symposium Traitements Injectables
BRIEF published on 07/29/2026 at 13:29, 1 month 17 days ago Medincell Partner Teva Reports Strong UZEDY® Sales Growth Net Sales Growth Revenue Outlook Schizophrenia Treatment Teva Pharmaceuticals Long-acting Injectable
BRIEF published on 07/29/2026 at 13:29, 1 month 17 days ago Record sales for UZEDY® in the second quarter of 2026 Schizophrenia Teva Pharmaceuticals UZEDY Sales 2026 Forecast Medincell Royalties
BRIEF published on 07/29/2026 at 13:29, 1 month 17 days ago Ventes record pour UZEDY® au deuxième trimestre 2026 Schizophrénie Teva Pharmaceuticals Ventes UZEDY Prévisions 2026 Royalties Medincell
BRIEF published on 07/29/2026 at 13:29, 1 month 17 days ago Le partenaire de Medincell, Teva, annonce une forte croissance des ventes d'UZEDY® Croissance Des Ventes Nettes Traitement De La Schizophrénie Perspectives De Revenus Teva Pharmaceuticals Injectable À Action Prolongée
PRESS RELEASE published on 07/29/2026 at 13:24, 1 month 17 days ago Inside Information / Other news releases Teva's UZEDY® achieves record Q2 net sales of $77M, up 43% YoY. Olanzapine LAI FDA action anticipated in Q4 2026. Medincell's innovative long-acting injectable treatments show promising results Record Sales Medincell Teva UZEDY Long-acting Injectable
PRESS RELEASE published on 07/29/2026 at 13:24, 1 month 17 days ago Informations privilégiées / Autres communiqués Ventes record d'UZEDY® de 77 M$ au 2ème trimestre 2026 (+43% sur un an), Teva relève ses prévisions. Annonce sur les résultats de Teva : ir.tevapharm.com Schizophrénie Ventes Record Teva Pharmaceuticals UZEDY® Prévisions 2026
BRIEF published on 07/28/2026 at 20:26, 1 month 17 days ago Publication of the 2025/2026 Universal Registration Document by Medincell Financial Report General Assembly CSR Registration Document Medincell
Published on 09/15/2026 at 15:20, 3 minutes ago MicroVision Showcases Expanding Perception Portfolio at IAA Transportation 2026
Published on 09/15/2026 at 15:00, 23 minutes ago Bitterroot Resources Awarded US$5.22 Million by the US Dept of War for the LM Nickel-Copper Exploration Project, Michigan
Published on 09/15/2026 at 15:00, 23 minutes ago Core Silver Completes Acquisition of Arcus Development Group
Published on 09/15/2026 at 14:31, 52 minutes ago First Breach Secures Federal Explosives License for Attritible Drone Manufacturing
Published on 09/15/2026 at 15:16, 7 minutes ago EQS-Adhoc: SMA Solar Technology AG: CEO Absent Due to Illness
Published on 09/15/2026 at 15:05, 18 minutes ago Prophix® Unlocks Value for Customers with New Agent and Secure AI Ecosystem Access
Published on 09/15/2026 at 14:46, 37 minutes ago Bio-Gate AG: First Comparative Clinical Data on HyProtect™ in Trauma Care—Significantly Higher Treatment Success Rate for Infected, Non-Healed Femur Fractures
Published on 09/15/2026 at 14:45, 38 minutes ago Momentus Technologies Launches MomentusMAX, an AI Platform Built for Venues, and Brings MAX for Sales to General Availability
Published on 09/15/2026 at 14:10, 1 hour 13 minutes ago Carbon credits move into the Boardroom as Nine in Ten Buyers Report Real Business Gains
Published on 09/15/2026 at 07:00, 8 hours 23 minutes ago AXA announces its 2027-2029 strategy and financial targets
Published on 09/15/2026 at 07:00, 8 hours 23 minutes ago AXA annonce son plan stratégique 2027-2029 ainsi que ses objectifs financiers
Published on 09/14/2026 at 18:21, 21 hours 2 minutes ago Reporting on share buyback transactions carried out between September 7 and September 10, 2026
Published on 09/14/2026 at 18:21, 21 hours 2 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 7 et le 10 septembre 2026
Published on 09/14/2026 at 18:00, 21 hours 23 minutes ago Mint franchit une nouvelle étape de sa transformation BtoB : deux signatures majeures viennent conforter une stratégie de croissance récurrente en accélération
